Cecília Garlanda

Also affiliated with IRCCS Humanitas Research Hospital

Immunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The first case of COVID-19 treated with the complement C3 inhibitor AMY-101”.

The first case of COVID-19 treated with the complement C3 inhibitor AMY-101

Clinical Immunology(2020)10.1016/j.clim.2020.108450

N/A

0DataRank · unranked

297 citations

Annalisa Ruggeri, Antonio M. Risitano, Piera Angelillo, Despina Yancopoulou, Dimitrios C. Mastellos +7 more

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

Clinical Immunology(2020)10.1016/j.clim.2020.108598

N/A

0DataRank · unranked

265 citations

Bruno G. P. Pires da Silva, Benedito Antônio Lopes da Fonseca, Natasha Peixoto Fonseca, Maria Auxiliadora‐Martins, Sara Mastaglio +18 more

IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8

Theranostics(2020)10.7150/thno.47435

N/A

0DataRank · unranked

59 citations

Stéphanie Zandee, Jesús Amo‐Aparicio, Marc Charabati, Alexandre Prat, Cecília Garlanda +4 more

Extracellular and nuclear roles of IL-37 after spinal cord injury

Brain Behavior and Immunity(2020)10.1016/j.bbi.2020.09.026

N/A

0DataRank · unranked

16 citations

Alba Sánchez‐Fernández, Suzhao Li, Elan Eisenmesser, Cecília Garlanda, Charles A. Dinarello +2 more